DiaMedica Therapeutics (DMAC) Cash from Financing Activities (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted Cash from Financing Activities of $132,000 for Q2 2026, down 18.0% from $161,000 a year earlier and down 68.3% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at DiaMedica Therapeutics was $44.17 million; for FY2025, it was $43.88 million, up 265.8% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- In prior years, DiaMedica Therapeutics' Cash from Financing Activities was $11.99 million in FY2024 (-67.4%), $36.84 million in FY2023, -$6,000 in FY2022 and $30.09 million in FY2021 (+4.3%).
- The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities since Q1 2025.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $417,000 (Q1 2026), $12.09 million (Q4 2025) and $31.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | DiaMedica Therapeutics | 445.97 Mn | 445.97 Mn | - | 132,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 417,000.00 |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | 31.53 Mn |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | 11.75 Mn |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | 36.85 Mn |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Sep 30, 2021 | 29.87 Mn |
API Access
DiaMedica Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();